Is the Supreme Court’s Abortion Pill Ruling Actually a Feint?
The justices kept the status quo while the Fifth Circuit reviews Louisiana’s challenge to the FDA rule.
5 Articles
5 Articles
The mifepristone whiplash story and how to cover it
The legal fight over mifepristone has entered yet another volatile phase. In early May 2026, the 5th U.S. Circuit Court of Appeals ruled that mifepristone must be dispensed in person, effectively blocking telehealth prescribing and mail delivery nationwide. That decision would have upended a system that, since 2021, has allowed patients to access the drug via telemedicine and pharmacies. But on May 14, the Supreme Court stepped in again, allowi…
The U.S. Supreme Court has decided to preserve access to mifepristone, a medicine used in most abortions in the United States. The decision prevents, for the time being, restrictions defended by conservative states from coming into force and maintains the current rules of the Food and Drug Administration, which allow the distribution of medication by pharmacies and mail, without any need for face-to-face consultation. In practice, women will con…
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
